CPC C12Q 1/6886 (2013.01) [C12Q 2600/112 (2013.01); C12Q 2600/158 (2013.01); C12Q 2600/178 (2013.01)] | 15 Claims |
1. A method for detecting microRNAs (miRNA) and long non-coding RNAs (IncRNAs) in human blood and assessing radiomic features, from a human subject having an intraductal papillary mucinous neoplasm (IPMN) comprising:
detecting a level of each of the following miRNAs in a blood sample from the human subject: miR-200a-3p, miR-1185-5p, miR-33a-5p, miR-574-4p, and miR-663b; wherein said detecting is carried out using a method selected from among hybridization assay, RNA sequencing, or amplification assay;
detecting a level of each of the following lncRNAs in the blood sample from the human subject: ADARB2-AS1, ANRIL, GLIS3-AS1, LINC00472, MEG3, PANDA, PVT1, and UCA1; and
extracting quantitative radiomic features from an image of abdominal visceral fat from the human subject; wherein the quantitative radiomic features comprise one or more of the following: Fourier Descriptor Layer 1, Histogram Energy Layer 1, Histogram Entropy Layer 1, Co-occurrence matrix features OF1G1 CONTRAST Layer 1, Run-length features G1 DO HGRE Layer 1, Run-length features G1 DO LGRE Layer 1, Laws features E5 E5 Energy Layer 1, Laws features L5 S5 Energy Layer 1, Laws features R5 E5 Energy Layer 1, Wavelet decomposition P1 L3 C1 Layer 1, Wavelet decomposition P1 L3 C2 Layer 1, Border length (Pxl), Width (Pxl), and Radius of largest enclosed ellipse.
|